Researchers sought to determine whether survival outcomes for patients with early breast cancer was better with NACT or ACT when pCR was not achieved.

Researchers sought to determine whether zanubrutinib would be effective for patients with CLL/SLL who were intolerant to other BTK inhibitors.

The approval for HR-SMM was based on data from the phase 3 AQUILA study, which evaluated Darzalex Faspro in adults aged 31 years and older with HR-SMM.

A systematic review with meta-analysis compared single- versus multi-port robotic approaches in prostate and renal surgery.

Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population.

A study on oncology care models demonstrates the potential of nurse practitioners to lead multidisciplinary oncologic care teams.

Rates of overall survival, prostate cancer-specific death, and distant metastasis were similar in patients who received prophylactic whole pelvic radiotherapy compared to those who received ...

Recognizing these differences underscores the importance of age-tailored supporting care and ongoing assessment in the early-onset NETs patient population,” said Udhayvir Singh Grewal, MD.

No differences seen among one-, two-, and three-year interval cancer predictions, age quartiles, or breast densities.

We recommend that CTC should be routinely assessed and measured at diagnosis as part of risk evaluation,” study researchers wrote.

Researchers evaluated whether long-term treatment with PPIs is associated with an increased risk for early-onset CRC among adults aged younger than 50 years.

SARS-CoV-2 mRNA vaccination within 100 days of ICI initiation was associated with increased overall survival in patients with NSCLC or metastatic melanoma.